Literature DB >> 22439277

Serum cytokine profile in leprosy and its correlation with clinico-histopathological profile.

Neha Kawatra Madan1, Kiran Agarwal, Ram Chander.   

Abstract

OBJECTIVES: To analyse the serum levels of cytokines in leprosy patients, to correlate them with clinico-histopathological profile, and to study the effect of standard multidrug therapy on serum cytokine levels.
DESIGN: Serum immunoassays of TNF-alpha, IFN-gamma, IL-1 beta and IL-10 were performed by ELISA in 61 newly diagnosed cases of leprosy before starting therapy and during reactional episodes. Of these, cytokine assays could be performed in 17 cases after completion of therapy.
RESULTS: Levels of all the studied cytokines were significantly raised in cases compared to controls (P < 0.05). Levels of TNF-alpha and IFN-gamma were significantly raised in paucibacillary cases whereas all the studied cytokines were raised in multibacillary cases with rise in IL-1 beta and IL-10 being statistically significant (P < 0.001). No significant difference was however noted between TT and BT type; and BB, BL and LL types. All the studied cytokines were raised in reactional cases as compared to non-reactional cases. Comparing Type 2 reaction (T2R) and Type 1 reaction (T1R) cases, levels of IFN-gamma, IL-1 beta and IL-10 were higher in T2R cases but only IL-10 was found to be statistically significant (P = 0.05) while TNF-alpha was higher in T1R cases. Post therapy serum levels of all the studied cytokines were significantly lower than pretherapy levels (P < 0.05) and were comparable to controls. Among the paucibacillary cases, levels of all the cytokines were seen to decrease after 6 months of standard multidrug therapy. In the multibacillary cases, mean levels of the cytokines were found to decrease after 1 year of therapy except IFN-gamma.
CONCLUSION: Serum cytokine estimation may have a significant role in classifying various forms of leprosy and can be used to monitor therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22439277

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  11 in total

1.  Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.

Authors:  Fátima Regina Vilani-Moreno; Vânia Nieto Brito-de-Souza; Sônia Maria Usó Ruiz Silva; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Ana Paula Campanelli; Jaison Antonio Barreto; Marcos da Cunha Lopes Virmond
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

2.  Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.

Authors:  Rosane Dias Costa; Vanessa Amaral Mendonça; Frederico Marianetti Soriani; Sandra Lyon; Rachel Adriana Penido; Ana Maria Duarte Dias Costa; Marina Dias Costa; Fabio de Souza Terra; Mauro Martins Teixeira; Carlos Mauricio de Figueiredo Antunes; Antonio Lúcio Teixeira
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

Review 3.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

4.  Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy.

Authors:  Nadja de Lima Santana; Jamile Leão Rêgo; Joyce Moura Oliveira; Lucas Frederico de Almeida; Marcos Braz; Lídia Maria Medeiros Machado; Paulo Roberto Lima Machado; Léa Cristina Castellucci
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-03-02       Impact factor: 2.743

5.  Cytokine Levels in Neural Pain in Leprosy.

Authors:  Débora Bartzen Moraes Angst; Roberta Olmo Pinheiro; Joyce Soares da Silva Vieira; Roberta Arnoldi Cobas; Mariana de Andréa Vilas-Boas Hacker; Izabela Jardim Rodrigues Pitta; Louise Mara Giesel; Euzenir Nunes Sarno; Márcia Rodrigues Jardim
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

Review 6.  Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic Review.

Authors:  D C B Cortela; A L de Souza Junior; M C L Virmond; E Ignotti
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

7.  A new era of diagnostic modalities for type 1 leprosy reactions: Promise for the future.

Authors:  Mary Thomas
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

Review 8.  Leprosy in Denmark 1980-2010: a review of 15 cases.

Authors:  Huma Aftab; Susanne D Nielsen; Ib C Bygbjerg
Journal:  BMC Res Notes       Date:  2016-01-05

9.  The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.

Authors:  Edessa Negera; Stephen L Walker; Kidist Bobosha; Yonas Bekele; Birtukan Endale; Azeb Tarekegn; Markos Abebe; Abraham Aseffa; Hazel M Dockrell; Diana N Lockwood
Journal:  Front Immunol       Date:  2018-02-09       Impact factor: 7.561

10.  Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum.

Authors:  Douglas Eulálio Antunes; Isabela Maria Bernardes Goulart; Mayara Ingrid Sousa Lima; Patrícia Terra Alves; Paula Cristina Brígido Tavares; Luiz Ricardo Goulart
Journal:  J Immunol Res       Date:  2019-11-07       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.